Skip to content

Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis

Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00306085
Enrollment
20
Registered
2006-03-22
Start date
2005-04-30
Completion date
2006-04-30
Last updated
2006-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Vascular Diseases

Keywords

Peripheral arterial disease,, blood marrow cells,, therapeutic angiogenesis.

Brief summary

Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic limbs has been shown to improve collateral vessel formation. In the present study the safety and feasibility of autologous blood mononuclear cells implantation will be investigated in patients with severe peripheral atherosclerosis.Twenty cases will be enrolled. Improvement in the ankle-brachial pressure index (ABI:\>0.1), ischemic ulcers and angiography as well as laser doppler flow will be evaluated until six months.

Interventions

GENETICAutologous bone marrow cells

Sponsors

University of Naples
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
45 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of third or fourth class of peripheral atherosclerosis

Exclusion criteria

* Insuline dependent diabetes * Cancer

Design outcomes

Primary

MeasureTime frame
Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.

Secondary

MeasureTime frame
Angiographic and laser doppler measurements after six months from treatment.

Countries

Italy

Contacts

Primary ContactHeidi Eisele
heidi.eisele@unina2.it+39 081/5665685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026